Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ProQuad concomitant versus separate administration with Infanrix hexa booster in healthy toddlers
2006-004129-27Phase 3Completed
- Sponsor
- Sanofi
- Start
- Oct 2006
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of varicella virus vaccine and pertussis filamentous haemagglutinin in measles, mumps, rubella and 7 more (3 arms), sponsored by Sanofi. Primary endpoints: Immunogenicity response rates for measles, mumps, rubella, and varicella, Immunogenicity response rates for hepatitis B and Haemophilus influenzae type b and 1 more. Started Oct 2006; status: completed.
02
Drugs
varicella virus vaccinepertussis filamentous haemagglutinin
03
Conditions
measlesmumpsrubellachickenpoxdiphtheria
Beyond the preview
Go deeper on 2006-004129-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004129-27.